Artículos del autor

solaci

Acute coronary syndromes

Post MI Betablockers for Good?

Patients receiving optimal medical treatment after MI do not seem to benefit from betablockers in the long...
solaci -
Institutional News

SOLACI Sessions Changes Authorities

Dr. Gustavo Vignolo (Uruguay) has taken office as SOLACI Sessions Director after the successful administration of Doctor...
solaci -
Institutional News

SOLACI Research Continues to Consolidate its Investigation Registries | REDCAP SOLACI

The Latin American Society of Interventional Cardiology has decided to hire the REDCap database platform to keep developing...
solaci -
Chronic Ischemic cardiopathy

Impact of FFR After Stenting: Useful or Mere Fun Fact?

Suboptimal fractional flow reserve (FFR) results after stenting only have a moderate impact on clinical hard points...
solaci -
Institutional News

LATAM Bif Registry: March 2021 Report

Know the new data from The Latin American Registry of Coronary Bifurcation Percutaneous Intervention  from March 2021....
solaci -
Antiplatelet

Short Therapy and Monotherapy, Plenty of Evidence

A short dual antiplatelet therapy (DAPT) of 1 to 3 months followed by P2Y12 inhibitor monotherapy after...
solaci -
Institutional News

The Most Read Articles in Interventional Cardiology of March

01- Surgeons’ Claim on Low-Risk Patients with Aortic Stenosis Recent randomized trials including low-risk patients showed positive results...
solaci -
Coronary disease

Lower Mortality with Rechanneling vs. Medical Therapy

We had to wait for it, but we have finally seen a benefit in hard endpoints—such as...
solaci -